Cellectricon AB, a collaborative research organization dedicated to advancing drug discovery and research in the areas of chronic pain and CNS diseases, today announced the launch of a novel assay platform for in vitro neurodegenerative disease research. The platform, based on a patent-pending microfluidics technology, has been developed over the ... Read More...
Recent Posts
- The Engine Listed Among the Ten Best Digital Marketing Agencies in Europe January 7, 2021
- Icelandic tarot deck wins International Tarot Foundation prizes December 7, 2020
- Iceland Aviation Academy becomes market leader in the Nordic region November 30, 2020
- Valka introduces a revolutionary salmon cutter November 26, 2020
- Comply by TBI – The next generation of VAT Compliance software November 25, 2020
Submit Your Press Release at eNewsWire
eNewsWire is an online press release service offering both free and paid distribution. eNewWire distributes business, organisational and personal news and press releases using the Internet. Submit your press release here.